/biz/ - Business & Finance

>>55475814
If you're talking about CRNX it's a combination of data the company releases in corporate presentations and PR's and also peer reviewed paper about the existing class of drugs for that indication (acromegaly). For example pic related is from a paper comparing injectable acromegaly drugs versus oral acromegaly drug (CRNX's competitor, mycappsa aka oral oct).

I use the papers to see how CRNX's competitor drugs are doing and what the standard of clinical trial response rate should be from CRNX's drug.

>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8550586/
>Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results
>Published in Pituitary
>The official publication of the Pituitary Society and the Growth Hormone Research Society